Sort
51,593 grants matching “hepatitis”
Nebulized ALX1 as a treatment for Pseudomonas aeruginosa infections in bronchiectasis patients
$1,000,000Nathan Allan Stasko · Vast Therapeutics, Inc. · R44 · FY2025 · AI
A Multi-Center Group to Study Acute Liver Failure
$1,000,000William M Lee · Ut Southwestern Medical Center · U01 · FY2017 · DK
Advancing clemizole for hepatitis C: towards a pre-IND package--Phase II
$1,000,000Brian S Murphy · Eiger Group International, Inc. · R42 · FY2011 · AI
High Tc susceptometer for magnetic measure of body iron
$1,000,000Columbia University Health Sciences · R01 · FY2001 · DK
Preclinical development of capsid assembly modulators for the treatment of chronic hepatitis B virus infection
$1,000,000Glen Andrew Coburn · Venatorx Pharmaceuticals, Inc. · R44 · FY2023 · AI
Liver Center
$1,000,000University Of California San Francisco · P30 · FY2002 · DK
A single antiviral to treat multiple opportunistic infections
$1,000,000Stacy Remiszewski · Evrys Bio, Llc · R44 · FY2020 · AI
Advancing clemizole for hepatitis C: towards a pre-IND package--Phase II
$1,000,000Brian S Murphy · Eiger Group International, Inc. · R42 · FY2013 · AI
A Multi-Center Group to Study Acute Liver Failure
$1,000,000William M Lee · Ut Southwestern Medical Center · U01 · FY2018 · DK
CDC Racial and Ethnic Approaches to Community Health Across the US
$1,000,000National Institute On Minority Health And Health Disparities · Y01 · FY2010 · MD
Phase II STTR development of an intranasal/oral Spirulina-based PfCSP malaria vaccine.
$1,000,000Nhi Khuong · Lumen Bioscience, Inc. · R42 · FY2021 · AI
AIDS INTERNATIONAL TRAINING AND RESEARCH PROGRAM
$1,000,000Weill Medical College Of Cornell Univ · D43 · FY2003 · TW
LIVER PATHOBIOLOGY AND GENE THERAPY RESEARCH CORE CENTER
$1,000,000Yeshiva University · P30 · FY2000 · DK
Recombinant yeast vaccines for sensitive and drug-resistant M. tuberculosis
$1,000,000Timothy Rodell · Globeimmune, Inc. · R01 · FY2015 · AI
Determining how the evolution of the coronavirus macrodomain contributes to its biochemical and virological functions
$1,000,000Anthony Fehr · University Of Kansas Center For Research Inc · · FY2025 · BIO
Data Coordinating Center for the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Continuation
$999,999David M Shade · Johns Hopkins University · U24 · FY2025 · DK
Therapeutic antibodies for treating liver fibrosis
$999,999Lauren Jennifer Schwimmer · Abalone Bio, Inc. · R44 · FY2022 · DK
TLC-1235, a controlled-release mitochondrial protonophore (CRMP), for the reversal of insulin resistance in patients with severe lipodystrophy
$999,999Robert Paul Myers · Orsobio, Inc. · R44 · FY2024 · DK
Therapeutic antibodies for treating liver fibrosis
$999,999Lauren Jennifer Schwimmer · Abalone Bio, Inc. · R44 · FY2023 · DK
TLC-1235, a controlled-release mitochondrial protonophore (CRMP), for the reversal of insulin resistance in patients with severe lipodystrophy
$999,999Robert Paul Myers · Orsobio, Inc. · R44 · FY2023 · DK
Mid Southern Primary Care Networks Node
$999,998Li-Tzy T Wu · Duke University · UG1 · FY2019 · DA
A single antiviral to treat multiple opportunistic infections
$999,998Stacy Remiszewski · Evrys Bio, Llc · R44 · FY2023 · AI
Expanding Vietnamese Community and Academic Infrastructure for Health Research
$999,998Bang H Nguyen · Cancer Prevention Instit Of California · RC4 · FY2010 · MD
A single antiviral to treat multiple opportunistic infections
$999,997Stacy Remiszewski · Evrys Bio, Llc · R44 · FY2019 · AI
Rapid, Point-of-Care Nucleic Acid Test for HCV
$999,841Hyundae Cho · Crosslife Technologies, Inc. · R44 · FY2019 · DK